PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

MMP Inhibitor Ilomastat Improves Survival of Mice Exposed to gamma-Irradiation.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30025561 ↗2018Reported benefit

MMP Inhibitor Ilomastat Improves Survival of Mice Exposed to gamma-Irradiation.

MouseRadiationPretreatment before total body irradiation

Model: Total body gamma irradiation, including 6 Gy whole body irradiation

Ilomastat treatment increased survival of mice after total body irradiation, and pretreatment promoted recovery of haematological and immunological cells after 6 Gy gamma irradiation.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.